JOUNCE THERAPEUTICS INC – US4811161011 / BDRW1N9
To qualify for ISA inclusion, a share has to be officially listed on a recognised stock exchange (see ISA Guidance https://www.gov.uk/guidance/stocks-and-shares-investments-for-isa-managers#shareinv) or, from 5 August 2013, admitted to trading on a recognised stock exchange in the European Economic Area (EEA) or the UK. From the initial research we have carried out, this share appears to have secondary listing and traded on the Berlin Open Market (see link below) therefore, on that basis, it should qualify for stocks & shares ISA inclusion.
Jounce Therapeutics Inc – US4811161011 – Börse Berlin (boerse-berlin.com)